{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:32Z","timestamp":1791239072210,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,14]]},"DOI":"10.1097\/01.aids.0000252060.80704.68","type":"journal-article","created":{"date-parts":[[2006,11,3]],"date-time":"2006-11-03T09:46:20Z","timestamp":1162547180000},"page":"2183-2191","source":"Crossref","is-referenced-by-count":161,"title":["Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy"],"prefix":"10.1097","volume":"20","author":[{"given":"Olivier","family":"Lortholary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendoline","family":"Poizat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Boibieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Botterel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Ch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJM198909213211205","article-title":"Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome","volume":"321","author":"Chuck","year":"1989","journal-title":"N Engl J Med"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-104-2-234","article-title":"Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment","volume":"104","author":"Zuger","year":"1986","journal-title":"Ann Intern Med"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199203193261203","article-title":"A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome","volume":"326","author":"Powderly","year":"1992","journal-title":"N Engl J Med"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","article-title":"Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?","volume":"57","author":"Charlier","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/173.1.219","article-title":"Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients","volume":"173","author":"Maenza","year":"1996","journal-title":"J Infect Dis"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00126334-199908010-00011","article-title":"Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand","volume":"21","author":"Tansuphasawadikul","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","article-title":"Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients","volume":"14","author":"Hakim","year":"2000","journal-title":"AIDS"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl S1","key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/49.suppl_1.57","article-title":"Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B","volume":"49","author":"Chen","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","article-title":"Epidemiology of HIV-associated cryptococcosis in France (1985\u20132001): comparison of the pre- and post-HAART eras","volume":"18","author":"Dromer","year":"2004","journal-title":"AIDS"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome","volume":"324","author":"Bozzette","year":"1991","journal-title":"N Engl J Med"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1097\/00002030-200011100-00029","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy","volume":"14","author":"Martinez","year":"2000","journal-title":"AIDS"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/00002030-200107270-00015","article-title":"Cessation of secondary prophylaxis in patients with cryptococcosis","volume":"15","author":"Nwokolo","year":"2001","journal-title":"AIDS"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/339680","article-title":"A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy","volume":"185","author":"Aberg","year":"2002","journal-title":"J Infect Dis"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study","volume":"36","author":"Vibhagool","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/381261","article-title":"Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study","volume":"38","author":"Mussini","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/clinids\/23.1.82","article-title":"Epidemiology of cryptococcosis in France: 9-year survey (1985\u20131993)","volume":"23","author":"Dromer","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis","volume":"326","author":"Saag","year":"1992","journal-title":"N Engl J Med"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1086\/338267","article-title":"A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study","volume":"185","author":"Lundgren","year":"2002","journal-title":"J Infect Dis"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study","volume":"340","author":"Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002030-200101050-00006","article-title":"Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy","volume":"15","author":"Jouan","year":"2001","journal-title":"AIDS"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/338816","article-title":"Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis","volume":"34","author":"Zeller","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00002030-200007070-00014","article-title":"Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study","volume":"14","author":"Furrer","year":"2000","journal-title":"AIDS"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/315471","article-title":"Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study","volume":"181","author":"Mussini","year":"2000","journal-title":"J Infect Dis"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","article-title":"Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups","volume":"344","author":"Ledergerber","year":"2001","journal-title":"N Engl J Med"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20142002. Recommendations of the U S Public Health Service and the Infectious Diseases Society of America","volume":"137","author":"Masur","year":"2002","journal-title":"Ann Intern Med"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France","volume":"19","author":"Lortholary","year":"2005","journal-title":"AIDS"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/clinids\/18.5.789","article-title":"Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis","volume":"18","author":"Powderly","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1310\/NQXR-ULMG-MM1B-3T2B","article-title":"Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease","volume":"1","author":"Aberg","year":"2000","journal-title":"HIV Clin Trials"},{"key":"R37-7-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"R38-7-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R39-7-20210130","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"R40-7-20210130","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/424676","article-title":"Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy","volume":"190","author":"Dheda","year":"2004","journal-title":"J Infect Dis"},{"key":"R41-7-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002030-200301030-00010","article-title":"Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia","volume":"17","author":"Morris","year":"2003","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200611140-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:22:54Z","timestamp":1618280574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200611140-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,14]]},"references-count":40,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000252060.80704.68","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,14]]}}}